Malaria.com Vectors Issue

News

The Malaria Fighter

After a knee-to-knee chat with this hamlet’s chief in the local malaria clinic as rain hammered the tin roof, Rear Adm. R. Timothy Ziemer reached into his pocket for his usual thank-you gift. The clinic was well run, and there was a big turnout of mothers grateful for the free mosquito nets.Accepting the thick gold-colored […]

Karen Masterson - Malaria Project

What Ebola Can Learn From Malaria

Famous experts, ranging from Paul Farmer to Jeffery Sachs, have tried to use reason to show why investments in clinics go further to stop diseases like Ebola than do investments in vaccines and drugs.

Read All News

Editorial

Claire Standley, Editor

World Malaria Day 2014 – How Best to Invest in Malaria Prevention and Control

Each year, April 25 provides an opportunity to reflect on the current status of the fight against malaria. We are in the middle year of the World Malaria Day theme of “Invest in the Future. Defeat Malaria,” which is set to last until 2015. Funding for malaria control and prevention, as with all international public health endeavors, has always been perceived as a critical issue, but there is a refreshing diversity to the ways in which it is being discussed this World Malaria Day.

Read All Blog Posts

Research

A Country on the Verge of Malaria Elimination – The Kingdom of Saudi Arabia

Significant headway has been made in the global fight against malaria in the past decade and as more countries enter the elimination phase, attention is now focused on identifying effective strategies to shrink the malaria map. Saudi Arabia experienced an outbreak of malaria in 1998, but is now on the brink of malaria elimination, with […]

IgG1 and IgG4 Antibody Responses to the Anopheles gambiae Salivary Protein gSG6

Human antibody response to the Anopheles gambiae salivary protein gSG6 has recently emerged as a potentially useful tool for malaria epidemiological studies and for the evaluation of vector control interventions. However, the current understanding of the host immune response to mosquito salivary proteins and of the possible crosstalk with early response to Plasmodium parasites is still very limited.

Targeting NAD+ Metabolism in the Human Malaria Parasite Plasmodium falciparum

Nicotinamide adenine dinucleotide (NAD+) is an essential metabolite utilized as a redox cofactor and enzyme substrate in numerous cellular processes. Elevated NAD+ levels have been observed in red blood cells infected with the malaria parasite Plasmodium falciparum, but little is known regarding how the parasite generates NAD+. In this study, researchers employed a mass spectrometry-based metabolomic approach to confirm that P. falciparum lacks the ability to synthesize NAD+ de novo and is reliant on the uptake of exogenous niacin.

Read All Research